1 suspended. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Suspended 1 |
Follow Demyelinating Diseases: new trials by email Literature Review of Demyelinating Diseases trials Research Report on Demyelinating Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis Placebo, Masitinib (4.5) - Progressive Multiple Sclerosis | Phase 3 | Suspended | AB Science | 800 | 2022-06-28 | 2026-05-06 |
Multiple Sclerosis, Chronic Progressive (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Chronic Disease (1) · Demyelinating Autoimmune Diseases, CNS (1) · Disease Attributes (1) · Immune System Diseases (1) · Multiple Sclerosis (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
masitinib (1)
AB Science (1)
France (1) · Greece (1) · Italy (1) · Poland (1) · Russia (1) · Spain (1) · Sweden (1) · Ukraine (1)